• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

告知方法范围:胎盘植入谱系疾病管理的机构审查。

Informing the Spectrum of Approaches: Institutional Review of Placenta Accreta Spectrum Disorders Management.

机构信息

Department of Obstetrics and Gynecology, McMaster University Medical Centre, Hamilton, ON.

Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, McMaster University Medical Centre, Hamilton, ON.

出版信息

J Obstet Gynaecol Can. 2022 Apr;44(4):365-371. doi: 10.1016/j.jogc.2021.10.013. Epub 2021 Nov 2.

DOI:10.1016/j.jogc.2021.10.013
PMID:34740850
Abstract

OBJECTIVE

Placenta accreta spectrum (PAS) is a condition defined by abnormal adherence of the placenta. Cesarean hysterectomy is the preferred management, but practice patterns vary based on local resources and expertise. We retrospectively reviewed the clinical course of patients diagnosed antenatally with PAS who underwent surgical management in our centre.

METHODS

We conducted a retrospective records review involving patients with an antenatal diagnosis of PAS between 2014 and 2019. The primary outcome was a composite score of maternal morbidity, and secondary outcomes were total estimated blood loss and composite neonatal morbidity. Patients were stratified based on the presence or absence of PAS on final pathology. Antenatal diagnosis by ultrasound and magnetic resonance imaging (MRI) was compared with final histologic diagnosis.

RESULTS

A total of 34 patients were diagnosed with PAS antenatally and managed at our institution. Final histology confirmed PAS in 29 patients. The overall composite morbidity rate was 44%, with no significant difference between patients with and without PAS on pathology (P = 0.355). Intraoperative blood loss was similar between the 2 groups (2374 ± 2212 mL vs. 1080 ± 852 mL; P = 0.232). The rate of composite neonatal morbidity was 47%. Ultrasound achieved a high positive predictive value in the diagnosis of PAS (96%) and more accurately predicted pathology than MRI.

CONCLUSIONS

PAS is associated with high rates of morbidity. Dissemination of our local experience serves to inform best practices in the management of this complex condition.

摘要

目的

胎盘植入谱系疾病(PAS)是一种由胎盘异常附着引起的疾病。剖宫产子宫切除术是首选的治疗方法,但实践模式因当地资源和专业知识而异。我们回顾性分析了在我们中心接受手术治疗的产前诊断为 PAS 的患者的临床过程。

方法

我们对 2014 年至 2019 年间产前诊断为 PAS 的患者进行了回顾性病历回顾。主要结局是产妇发病率的综合评分,次要结局是总估计失血量和新生儿发病率的综合评分。根据最终病理是否存在 PAS,将患者分层。超声和磁共振成像(MRI)的产前诊断与最终组织学诊断进行比较。

结果

共有 34 例患者产前诊断为 PAS 并在我们医院接受治疗。最终组织学证实 PAS 存在于 29 例患者中。总体复合发病率为 44%,病理上有 PAS 和无 PAS 的患者之间无显著差异(P=0.355)。两组术中失血量相似(2374±2212 mL 比 1080±852 mL;P=0.232)。复合新生儿发病率为 47%。超声在 PAS 的诊断中具有较高的阳性预测值,并且比 MRI 更准确地预测了病理。

结论

PAS 与高发病率相关。我们当地经验的传播有助于为这种复杂疾病的管理提供最佳实践。

相似文献

1
Informing the Spectrum of Approaches: Institutional Review of Placenta Accreta Spectrum Disorders Management.告知方法范围:胎盘植入谱系疾病管理的机构审查。
J Obstet Gynaecol Can. 2022 Apr;44(4):365-371. doi: 10.1016/j.jogc.2021.10.013. Epub 2021 Nov 2.
2
Impact of placenta accreta spectrum (PAS) pathology on neonatal respiratory outcomes in cesarean hysterectomies.胎盘植入谱系疾病(PAS)病理对剖宫产子宫切除术中新生儿呼吸结局的影响。
J Matern Fetal Neonatal Med. 2022 Dec;35(26):10692-10697. doi: 10.1080/14767058.2022.2157716. Epub 2022 Dec 15.
3
Importance of the gynecologic oncologist in management of cesarean hysterectomy for Placenta Accreta Spectrum (PAS).妇科肿瘤学家在胎盘植入谱系疾病(PAS)剖宫产子宫切除术中的管理作用
Gynecol Oncol. 2022 Sep;166(3):460-464. doi: 10.1016/j.ygyno.2022.06.025. Epub 2022 Jul 1.
4
Clinical Outcomes of a False-Positive Antenatal Diagnosis of Placenta Accreta Spectrum.胎盘植入谱系疾病产前假阳性诊断的临床结局。
Am J Perinatol. 2024 Jan;41(2):187-192. doi: 10.1055/a-1673-5103. Epub 2021 Oct 19.
5
The multidisciplinary management of placenta accreta spectrum (PAS) within a single tertiary centre: A ten-year experience.单一三级中心胎盘植入谱系疾病(PAS)的多学科管理:十年经验
Aust N Z J Obstet Gynaecol. 2019 Aug;59(4):550-554. doi: 10.1111/ajo.12932. Epub 2018 Dec 18.
6
Intracervical lakes as sonographic marker of placenta accreta spectrum disorder in patients with placenta previa or low-lying placenta.宫颈管内液性暗区作为前置胎盘或胎盘位置低患者胎盘植入谱系疾病的超声标志物。
Ultrasound Obstet Gynecol. 2020 Apr;55(4):460-466. doi: 10.1002/uog.21866. Epub 2020 Mar 6.
7
Placenta accreta spectrum: We can do better.胎盘植入谱系疾病:我们可以做得更好。
Aust N Z J Obstet Gynaecol. 2022 Jun;62(3):376-382. doi: 10.1111/ajo.13471. Epub 2022 Jan 4.
8
Placenta percreta is associated with more frequent severe maternal morbidity than placenta accreta.胎盘植入比胎盘粘连更常导致严重的产妇发病率。
Am J Obstet Gynecol. 2018 Aug;219(2):193.e1-193.e9. doi: 10.1016/j.ajog.2018.04.049. Epub 2018 May 5.
9
Placenta accreta spectrum disorders - detection rate and maternal outcomes following implementation of an institutional protocol.胎盘部位滋养细胞肿瘤谱系疾病-机构方案实施后的检出率和母婴结局。
J Obstet Gynaecol. 2022 Feb;42(2):202-208. doi: 10.1080/01443615.2021.1887110. Epub 2021 May 5.
10
Association between Antenatal Vaginal Bleeding and Adverse Perinatal Outcomes in Placenta Accreta Spectrum.胎盘植入谱系疾病中产前阴道出血与不良围产结局的关联
Medicina (Kaunas). 2024 Apr 22;60(4):677. doi: 10.3390/medicina60040677.

引用本文的文献

1
Two-dimensional ultrasound signs as predictive markers of massive peri-operative blood loss in placenta previa suspicious for placenta accreta spectrum (PAS) disorder.二维超声征象作为胎盘前置疑似胎盘植入谱系(PAS)障碍患者围手术期大量失血的预测标志物。
PLoS One. 2022 Oct 14;17(10):e0276153. doi: 10.1371/journal.pone.0276153. eCollection 2022.